1. A highly efficient recombinant canarypox virus-based vaccine against canine distemper virus constructed using the CRISPR/Cas9 gene editing method.
- Author
-
Gong Y, Chen T, Feng N, Meng X, Sun W, Wang T, Zhao Y, Yang S, Song X, Li W, Dong H, Wang H, He H, Wang J, Zhang L, Gao Y, and Xia X
- Subjects
- Animals, Canarypox virus immunology, Chick Embryo cytology, Chickens, Chlorocebus aethiops, Dogs, Female, Fibroblasts virology, Foxes immunology, Glycoproteins genetics, Glycoproteins immunology, Hemagglutinins, Viral genetics, Hemagglutinins, Viral immunology, Male, Mink immunology, Vaccines, Synthetic administration & dosage, Vaccines, Synthetic immunology, Vero Cells, Viral Fusion Proteins genetics, Viral Fusion Proteins immunology, Viral Vaccines administration & dosage, Viral Vaccines genetics, Antibodies, Viral blood, CRISPR-Cas Systems, Canarypox virus genetics, Distemper prevention & control, Distemper Virus, Canine genetics, Distemper Virus, Canine immunology, Gene Editing methods, Viral Vaccines immunology
- Abstract
Canine distemper virus (CDV) is the causative agent of canine distemper (CD), which is one of the most important infectious diseases affecting wild and domestic carnivores. Vaccination represents an effective approach to prevent CDV infection among domestic carnivores. Canarypox-vectored recombinant CD vaccines (such as Recombitek CDV, PureVax Ferret Distemper, and Merial) with the CDV hemagglutinin (H) and fusion (F) genes can induce a potent immune response in dogs and ferrets. However, the vaccine's effectiveness varies with the species. In the current study, we developed a highly efficient recombinant canarypox virus termed as "ALVAC-CDV-M-F-H/C5
- " that contained CDV virus-like particles (VLPs) by using the CRISPR/Cas9 gene editing method, which enabled concurrent expression of the matrix (M), H, and F genes. The recombinant strain provided faster seroconversion than the parent strain among minks as well as provided higher rates of antibody positivity than the parent strain among foxes and minks even before the administration of a second booster vaccination. We demonstrated, for the first time, that the CRISPR/Cas9 system can be applied for the rapid and efficient modification of the ALVAC-CDV-F-H genome and also that a high-dose new recombinant strain that produces CDV VLPs may present good outcomes in the prevention of CD among foxes and minks., (Copyright © 2020 Elsevier B.V. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF